Crystalline cis-(e)-4-(3-fluorophenyl)-2',3',4',9'-tetrahydro-n,n-dimethyl-2'-(1-oxo-3-phenyl-2-propenyl)-spirocyclohexane-1,1'1h-pyrido3,4-bindol-4-amine

摘要

The present invention relates to crystalline forms of cis-(E)-4-(3-Fluorophenyl)-2,3,4,9-tetrahydro-N,N-dimethyl-2-(1-oxo-3-phenyl-2-propenyl)-spiro[cyclohexane-1,1[1H]-pyrido[3,4-b]indol]-4-amine, pharmaceutical compositions and medicaments comprising these modifications, the use of these modifications as well as to a process for making the crystalline forms.